Skip to main content
main-content

Medicine Matters branded image Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in rheumatology

Safety snapshot

A summary of the safety data from the phase 3 trials of upadacitinib in psoriatic arthritis

Safety snapshot: Upadacitinib in patients with PsA

Access our overview of the key safety data from the phase 3 SELECT-PsA studies of upadacitinib in patients with psoriatic arthritis.

News

Pain management remains a ‘substantial unmet need’ in RA

Woman with wrist joint pain. Health care and medical concept.

Study findings suggest that approximately one-third of patients with rheumatoid arthritis have long-term unacceptable pain, despite control of inflammation in the majority of these people.

EULAR 2021 Virtual Congress coverage

Access news and expert commentary from the EULAR 2021 Virtual Congress.

MOST READ | COVID-19 & rheumatic disease

13-07-2021 | COVID-19 | News

Methotrexate dulls humoral but not cellular response to COVID-19 vaccine

UK research suggests there is a disparity between humoral and cellular immune responses to the first dose of the Pfizer–BioNTech COVID-19 vaccine in people on methotrexate monotherapy for psoriasis.

COVID-19 vaccination in patients with rheumatic diseases

Get answers to key questions with recommendations from professional organizations

MOST READ | Inflammatory arthritis

21-07-2021 | Rheumatoid arthritis | News

Pain management remains a ‘substantial unmet need’ in RA

Study findings suggest that approximately one-third of patients with rheumatoid arthritis have long-term unacceptable pain, despite control of inflammation in the majority of these people.

Common scores used in rheumatology

An at-a-glance reference guide to the scores that are commonly used in clinical trials & daily rheumatology practice

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

MOST READ | JAK inhibitors

07-06-2021 | EULAR 2021 | Conference coverage | News

Real-world studies point to similar effectiveness of JAK inhibitors and biologics

Findings from two real-world studies presented at the EULAR 2021 Virtual Congress suggest that JAK inhibitors and biologics are similarly effective for the treatment of inflammatory arthritis.

Safety snapshot: Upadacitinib in patients with PsA

Access our overview of the key safety data from the SELECT-PsA studies

MOST READ | Lupus

20-05-2021 | Systemic lupus erythematosus | News

RISE trial supports further investigation of dapirolizumab pegol for SLE

The addition of dapirolizumab pegol to standard therapy may warrant further investigation for the treatment of systemic lupus erythematosus, phase 2 trial results suggest.

Podcasts

Interviews with expert rheumatologists on patient care

Image Credits